Global Inherited Retinal Disease Treatment Supply, Demand and Key Producers, 2023-2029
The global Inherited Retinal Disease Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Inherited Retinal Disease Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inherited Retinal Disease Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inherited Retinal Disease Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Inherited Retinal Disease Treatment total production and demand, 2018-2029, (K Units)
Global Inherited Retinal Disease Treatment total production value, 2018-2029, (USD Million)
Global Inherited Retinal Disease Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Inherited Retinal Disease Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Inherited Retinal Disease Treatment domestic production, consumption, key domestic manufacturers and share
Global Inherited Retinal Disease Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Inherited Retinal Disease Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Inherited Retinal Disease Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Inherited Retinal Disease Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Spark Therapeutics, Novartis, Okuvision, NIDEK, Invitae, ZEISS INTERNATIONAL, MeiraGTx, Neurosoft and Astellas Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inherited Retinal Disease Treatment market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Inherited Retinal Disease Treatment Market, By Region:
1. How big is the global Inherited Retinal Disease Treatment market?
2. What is the demand of the global Inherited Retinal Disease Treatment market?
3. What is the year over year growth of the global Inherited Retinal Disease Treatment market?
4. What is the production and production value of the global Inherited Retinal Disease Treatment market?
5. Who are the key producers in the global Inherited Retinal Disease Treatment market?
This report studies the global Inherited Retinal Disease Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inherited Retinal Disease Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inherited Retinal Disease Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Inherited Retinal Disease Treatment total production and demand, 2018-2029, (K Units)
Global Inherited Retinal Disease Treatment total production value, 2018-2029, (USD Million)
Global Inherited Retinal Disease Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Inherited Retinal Disease Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Inherited Retinal Disease Treatment domestic production, consumption, key domestic manufacturers and share
Global Inherited Retinal Disease Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Inherited Retinal Disease Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Inherited Retinal Disease Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Inherited Retinal Disease Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Spark Therapeutics, Novartis, Okuvision, NIDEK, Invitae, ZEISS INTERNATIONAL, MeiraGTx, Neurosoft and Astellas Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inherited Retinal Disease Treatment market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Inherited Retinal Disease Treatment Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Gene Therapy
- Artificial Retina
- Neuroprotectant
- Hospital
- Clinic
- Spark Therapeutics
- Novartis
- Okuvision
- NIDEK
- Invitae
- ZEISS INTERNATIONAL
- MeiraGTx
- Neurosoft
- Astellas Pharma
- Bionic Vision Technologies
- Coave Therapeutics
- GenSight Biologics
- Ionis Pharmaceuticals
- IVERIC BIO
- Johnson & Johnson
- LKC Technologies
- Santen Pharmaceutical
- He Eye Hospital
- Bgi Genomics
1. How big is the global Inherited Retinal Disease Treatment market?
2. What is the demand of the global Inherited Retinal Disease Treatment market?
3. What is the year over year growth of the global Inherited Retinal Disease Treatment market?
4. What is the production and production value of the global Inherited Retinal Disease Treatment market?
5. Who are the key producers in the global Inherited Retinal Disease Treatment market?
1 SUPPLY SUMMARY
1.1 Inherited Retinal Disease Treatment Introduction
1.2 World Inherited Retinal Disease Treatment Supply & Forecast
1.2.1 World Inherited Retinal Disease Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Inherited Retinal Disease Treatment Production (2018-2029)
1.2.3 World Inherited Retinal Disease Treatment Pricing Trends (2018-2029)
1.3 World Inherited Retinal Disease Treatment Production by Region (Based on Production Site)
1.3.1 World Inherited Retinal Disease Treatment Production Value by Region (2018-2029)
1.3.2 World Inherited Retinal Disease Treatment Production by Region (2018-2029)
1.3.3 World Inherited Retinal Disease Treatment Average Price by Region (2018-2029)
1.3.4 North America Inherited Retinal Disease Treatment Production (2018-2029)
1.3.5 Europe Inherited Retinal Disease Treatment Production (2018-2029)
1.3.6 China Inherited Retinal Disease Treatment Production (2018-2029)
1.3.7 Japan Inherited Retinal Disease Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inherited Retinal Disease Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inherited Retinal Disease Treatment Major Market Trends
2 DEMAND SUMMARY
2.1 World Inherited Retinal Disease Treatment Demand (2018-2029)
2.2 World Inherited Retinal Disease Treatment Consumption by Region
2.2.1 World Inherited Retinal Disease Treatment Consumption by Region (2018-2023)
2.2.2 World Inherited Retinal Disease Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Inherited Retinal Disease Treatment Consumption (2018-2029)
2.4 China Inherited Retinal Disease Treatment Consumption (2018-2029)
2.5 Europe Inherited Retinal Disease Treatment Consumption (2018-2029)
2.6 Japan Inherited Retinal Disease Treatment Consumption (2018-2029)
2.7 South Korea Inherited Retinal Disease Treatment Consumption (2018-2029)
2.8 ASEAN Inherited Retinal Disease Treatment Consumption (2018-2029)
2.9 India Inherited Retinal Disease Treatment Consumption (2018-2029)
3 WORLD INHERITED RETINAL DISEASE TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inherited Retinal Disease Treatment Production Value by Manufacturer (2018-2023)
3.2 World Inherited Retinal Disease Treatment Production by Manufacturer (2018-2023)
3.3 World Inherited Retinal Disease Treatment Average Price by Manufacturer (2018-2023)
3.4 Inherited Retinal Disease Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inherited Retinal Disease Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inherited Retinal Disease Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Inherited Retinal Disease Treatment in 2022
3.6 Inherited Retinal Disease Treatment Market: Overall Company Footprint Analysis
3.6.1 Inherited Retinal Disease Treatment Market: Region Footprint
3.6.2 Inherited Retinal Disease Treatment Market: Company Product Type Footprint
3.6.3 Inherited Retinal Disease Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inherited Retinal Disease Treatment Production Value Comparison
4.1.1 United States VS China: Inherited Retinal Disease Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Inherited Retinal Disease Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Inherited Retinal Disease Treatment Production Comparison
4.2.1 United States VS China: Inherited Retinal Disease Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Inherited Retinal Disease Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Inherited Retinal Disease Treatment Consumption Comparison
4.3.1 United States VS China: Inherited Retinal Disease Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Inherited Retinal Disease Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Inherited Retinal Disease Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Inherited Retinal Disease Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023)
4.5 China Based Inherited Retinal Disease Treatment Manufacturers and Market Share
4.5.1 China Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Inherited Retinal Disease Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023)
4.6 Rest of World Based Inherited Retinal Disease Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Inherited Retinal Disease Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Gene Therapy
5.2.2 Artificial Retina
5.2.3 Neuroprotectant
5.3 Market Segment by Type
5.3.1 World Inherited Retinal Disease Treatment Production by Type (2018-2029)
5.3.2 World Inherited Retinal Disease Treatment Production Value by Type (2018-2029)
5.3.3 World Inherited Retinal Disease Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Inherited Retinal Disease Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Inherited Retinal Disease Treatment Production by Application (2018-2029)
6.3.2 World Inherited Retinal Disease Treatment Production Value by Application (2018-2029)
6.3.3 World Inherited Retinal Disease Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Spark Therapeutics
7.1.1 Spark Therapeutics Details
7.1.2 Spark Therapeutics Major Business
7.1.3 Spark Therapeutics Inherited Retinal Disease Treatment Product and Services
7.1.4 Spark Therapeutics Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Spark Therapeutics Recent Developments/Updates
7.1.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Inherited Retinal Disease Treatment Product and Services
7.2.4 Novartis Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Okuvision
7.3.1 Okuvision Details
7.3.2 Okuvision Major Business
7.3.3 Okuvision Inherited Retinal Disease Treatment Product and Services
7.3.4 Okuvision Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Okuvision Recent Developments/Updates
7.3.6 Okuvision Competitive Strengths & Weaknesses
7.4 NIDEK
7.4.1 NIDEK Details
7.4.2 NIDEK Major Business
7.4.3 NIDEK Inherited Retinal Disease Treatment Product and Services
7.4.4 NIDEK Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 NIDEK Recent Developments/Updates
7.4.6 NIDEK Competitive Strengths & Weaknesses
7.5 Invitae
7.5.1 Invitae Details
7.5.2 Invitae Major Business
7.5.3 Invitae Inherited Retinal Disease Treatment Product and Services
7.5.4 Invitae Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Invitae Recent Developments/Updates
7.5.6 Invitae Competitive Strengths & Weaknesses
7.6 ZEISS INTERNATIONAL
7.6.1 ZEISS INTERNATIONAL Details
7.6.2 ZEISS INTERNATIONAL Major Business
7.6.3 ZEISS INTERNATIONAL Inherited Retinal Disease Treatment Product and Services
7.6.4 ZEISS INTERNATIONAL Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 ZEISS INTERNATIONAL Recent Developments/Updates
7.6.6 ZEISS INTERNATIONAL Competitive Strengths & Weaknesses
7.7 MeiraGTx
7.7.1 MeiraGTx Details
7.7.2 MeiraGTx Major Business
7.7.3 MeiraGTx Inherited Retinal Disease Treatment Product and Services
7.7.4 MeiraGTx Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 MeiraGTx Recent Developments/Updates
7.7.6 MeiraGTx Competitive Strengths & Weaknesses
7.8 Neurosoft
7.8.1 Neurosoft Details
7.8.2 Neurosoft Major Business
7.8.3 Neurosoft Inherited Retinal Disease Treatment Product and Services
7.8.4 Neurosoft Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Neurosoft Recent Developments/Updates
7.8.6 Neurosoft Competitive Strengths & Weaknesses
7.9 Astellas Pharma
7.9.1 Astellas Pharma Details
7.9.2 Astellas Pharma Major Business
7.9.3 Astellas Pharma Inherited Retinal Disease Treatment Product and Services
7.9.4 Astellas Pharma Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Astellas Pharma Recent Developments/Updates
7.9.6 Astellas Pharma Competitive Strengths & Weaknesses
7.10 Bionic Vision Technologies
7.10.1 Bionic Vision Technologies Details
7.10.2 Bionic Vision Technologies Major Business
7.10.3 Bionic Vision Technologies Inherited Retinal Disease Treatment Product and Services
7.10.4 Bionic Vision Technologies Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Bionic Vision Technologies Recent Developments/Updates
7.10.6 Bionic Vision Technologies Competitive Strengths & Weaknesses
7.11 Coave Therapeutics
7.11.1 Coave Therapeutics Details
7.11.2 Coave Therapeutics Major Business
7.11.3 Coave Therapeutics Inherited Retinal Disease Treatment Product and Services
7.11.4 Coave Therapeutics Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Coave Therapeutics Recent Developments/Updates
7.11.6 Coave Therapeutics Competitive Strengths & Weaknesses
7.12 GenSight Biologics
7.12.1 GenSight Biologics Details
7.12.2 GenSight Biologics Major Business
7.12.3 GenSight Biologics Inherited Retinal Disease Treatment Product and Services
7.12.4 GenSight Biologics Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 GenSight Biologics Recent Developments/Updates
7.12.6 GenSight Biologics Competitive Strengths & Weaknesses
7.13 Ionis Pharmaceuticals
7.13.1 Ionis Pharmaceuticals Details
7.13.2 Ionis Pharmaceuticals Major Business
7.13.3 Ionis Pharmaceuticals Inherited Retinal Disease Treatment Product and Services
7.13.4 Ionis Pharmaceuticals Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Ionis Pharmaceuticals Recent Developments/Updates
7.13.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
7.14 IVERIC BIO
7.14.1 IVERIC BIO Details
7.14.2 IVERIC BIO Major Business
7.14.3 IVERIC BIO Inherited Retinal Disease Treatment Product and Services
7.14.4 IVERIC BIO Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 IVERIC BIO Recent Developments/Updates
7.14.6 IVERIC BIO Competitive Strengths & Weaknesses
7.15 Johnson & Johnson
7.15.1 Johnson & Johnson Details
7.15.2 Johnson & Johnson Major Business
7.15.3 Johnson & Johnson Inherited Retinal Disease Treatment Product and Services
7.15.4 Johnson & Johnson Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Johnson & Johnson Recent Developments/Updates
7.15.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.16 LKC Technologies
7.16.1 LKC Technologies Details
7.16.2 LKC Technologies Major Business
7.16.3 LKC Technologies Inherited Retinal Disease Treatment Product and Services
7.16.4 LKC Technologies Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 LKC Technologies Recent Developments/Updates
7.16.6 LKC Technologies Competitive Strengths & Weaknesses
7.17 Santen Pharmaceutical
7.17.1 Santen Pharmaceutical Details
7.17.2 Santen Pharmaceutical Major Business
7.17.3 Santen Pharmaceutical Inherited Retinal Disease Treatment Product and Services
7.17.4 Santen Pharmaceutical Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Santen Pharmaceutical Recent Developments/Updates
7.17.6 Santen Pharmaceutical Competitive Strengths & Weaknesses
7.18 He Eye Hospital
7.18.1 He Eye Hospital Details
7.18.2 He Eye Hospital Major Business
7.18.3 He Eye Hospital Inherited Retinal Disease Treatment Product and Services
7.18.4 He Eye Hospital Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 He Eye Hospital Recent Developments/Updates
7.18.6 He Eye Hospital Competitive Strengths & Weaknesses
7.19 Bgi Genomics
7.19.1 Bgi Genomics Details
7.19.2 Bgi Genomics Major Business
7.19.3 Bgi Genomics Inherited Retinal Disease Treatment Product and Services
7.19.4 Bgi Genomics Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Bgi Genomics Recent Developments/Updates
7.19.6 Bgi Genomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Inherited Retinal Disease Treatment Industry Chain
8.2 Inherited Retinal Disease Treatment Upstream Analysis
8.2.1 Inherited Retinal Disease Treatment Core Raw Materials
8.2.2 Main Manufacturers of Inherited Retinal Disease Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Inherited Retinal Disease Treatment Production Mode
8.6 Inherited Retinal Disease Treatment Procurement Model
8.7 Inherited Retinal Disease Treatment Industry Sales Model and Sales Channels
8.7.1 Inherited Retinal Disease Treatment Sales Model
8.7.2 Inherited Retinal Disease Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Inherited Retinal Disease Treatment Introduction
1.2 World Inherited Retinal Disease Treatment Supply & Forecast
1.2.1 World Inherited Retinal Disease Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Inherited Retinal Disease Treatment Production (2018-2029)
1.2.3 World Inherited Retinal Disease Treatment Pricing Trends (2018-2029)
1.3 World Inherited Retinal Disease Treatment Production by Region (Based on Production Site)
1.3.1 World Inherited Retinal Disease Treatment Production Value by Region (2018-2029)
1.3.2 World Inherited Retinal Disease Treatment Production by Region (2018-2029)
1.3.3 World Inherited Retinal Disease Treatment Average Price by Region (2018-2029)
1.3.4 North America Inherited Retinal Disease Treatment Production (2018-2029)
1.3.5 Europe Inherited Retinal Disease Treatment Production (2018-2029)
1.3.6 China Inherited Retinal Disease Treatment Production (2018-2029)
1.3.7 Japan Inherited Retinal Disease Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inherited Retinal Disease Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inherited Retinal Disease Treatment Major Market Trends
2 DEMAND SUMMARY
2.1 World Inherited Retinal Disease Treatment Demand (2018-2029)
2.2 World Inherited Retinal Disease Treatment Consumption by Region
2.2.1 World Inherited Retinal Disease Treatment Consumption by Region (2018-2023)
2.2.2 World Inherited Retinal Disease Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Inherited Retinal Disease Treatment Consumption (2018-2029)
2.4 China Inherited Retinal Disease Treatment Consumption (2018-2029)
2.5 Europe Inherited Retinal Disease Treatment Consumption (2018-2029)
2.6 Japan Inherited Retinal Disease Treatment Consumption (2018-2029)
2.7 South Korea Inherited Retinal Disease Treatment Consumption (2018-2029)
2.8 ASEAN Inherited Retinal Disease Treatment Consumption (2018-2029)
2.9 India Inherited Retinal Disease Treatment Consumption (2018-2029)
3 WORLD INHERITED RETINAL DISEASE TREATMENT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Inherited Retinal Disease Treatment Production Value by Manufacturer (2018-2023)
3.2 World Inherited Retinal Disease Treatment Production by Manufacturer (2018-2023)
3.3 World Inherited Retinal Disease Treatment Average Price by Manufacturer (2018-2023)
3.4 Inherited Retinal Disease Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Inherited Retinal Disease Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Inherited Retinal Disease Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Inherited Retinal Disease Treatment in 2022
3.6 Inherited Retinal Disease Treatment Market: Overall Company Footprint Analysis
3.6.1 Inherited Retinal Disease Treatment Market: Region Footprint
3.6.2 Inherited Retinal Disease Treatment Market: Company Product Type Footprint
3.6.3 Inherited Retinal Disease Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Inherited Retinal Disease Treatment Production Value Comparison
4.1.1 United States VS China: Inherited Retinal Disease Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Inherited Retinal Disease Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Inherited Retinal Disease Treatment Production Comparison
4.2.1 United States VS China: Inherited Retinal Disease Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Inherited Retinal Disease Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Inherited Retinal Disease Treatment Consumption Comparison
4.3.1 United States VS China: Inherited Retinal Disease Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Inherited Retinal Disease Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Inherited Retinal Disease Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Inherited Retinal Disease Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023)
4.5 China Based Inherited Retinal Disease Treatment Manufacturers and Market Share
4.5.1 China Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Inherited Retinal Disease Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023)
4.6 Rest of World Based Inherited Retinal Disease Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Inherited Retinal Disease Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Gene Therapy
5.2.2 Artificial Retina
5.2.3 Neuroprotectant
5.3 Market Segment by Type
5.3.1 World Inherited Retinal Disease Treatment Production by Type (2018-2029)
5.3.2 World Inherited Retinal Disease Treatment Production Value by Type (2018-2029)
5.3.3 World Inherited Retinal Disease Treatment Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Inherited Retinal Disease Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Inherited Retinal Disease Treatment Production by Application (2018-2029)
6.3.2 World Inherited Retinal Disease Treatment Production Value by Application (2018-2029)
6.3.3 World Inherited Retinal Disease Treatment Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Spark Therapeutics
7.1.1 Spark Therapeutics Details
7.1.2 Spark Therapeutics Major Business
7.1.3 Spark Therapeutics Inherited Retinal Disease Treatment Product and Services
7.1.4 Spark Therapeutics Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Spark Therapeutics Recent Developments/Updates
7.1.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Inherited Retinal Disease Treatment Product and Services
7.2.4 Novartis Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Okuvision
7.3.1 Okuvision Details
7.3.2 Okuvision Major Business
7.3.3 Okuvision Inherited Retinal Disease Treatment Product and Services
7.3.4 Okuvision Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Okuvision Recent Developments/Updates
7.3.6 Okuvision Competitive Strengths & Weaknesses
7.4 NIDEK
7.4.1 NIDEK Details
7.4.2 NIDEK Major Business
7.4.3 NIDEK Inherited Retinal Disease Treatment Product and Services
7.4.4 NIDEK Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 NIDEK Recent Developments/Updates
7.4.6 NIDEK Competitive Strengths & Weaknesses
7.5 Invitae
7.5.1 Invitae Details
7.5.2 Invitae Major Business
7.5.3 Invitae Inherited Retinal Disease Treatment Product and Services
7.5.4 Invitae Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Invitae Recent Developments/Updates
7.5.6 Invitae Competitive Strengths & Weaknesses
7.6 ZEISS INTERNATIONAL
7.6.1 ZEISS INTERNATIONAL Details
7.6.2 ZEISS INTERNATIONAL Major Business
7.6.3 ZEISS INTERNATIONAL Inherited Retinal Disease Treatment Product and Services
7.6.4 ZEISS INTERNATIONAL Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 ZEISS INTERNATIONAL Recent Developments/Updates
7.6.6 ZEISS INTERNATIONAL Competitive Strengths & Weaknesses
7.7 MeiraGTx
7.7.1 MeiraGTx Details
7.7.2 MeiraGTx Major Business
7.7.3 MeiraGTx Inherited Retinal Disease Treatment Product and Services
7.7.4 MeiraGTx Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 MeiraGTx Recent Developments/Updates
7.7.6 MeiraGTx Competitive Strengths & Weaknesses
7.8 Neurosoft
7.8.1 Neurosoft Details
7.8.2 Neurosoft Major Business
7.8.3 Neurosoft Inherited Retinal Disease Treatment Product and Services
7.8.4 Neurosoft Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Neurosoft Recent Developments/Updates
7.8.6 Neurosoft Competitive Strengths & Weaknesses
7.9 Astellas Pharma
7.9.1 Astellas Pharma Details
7.9.2 Astellas Pharma Major Business
7.9.3 Astellas Pharma Inherited Retinal Disease Treatment Product and Services
7.9.4 Astellas Pharma Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Astellas Pharma Recent Developments/Updates
7.9.6 Astellas Pharma Competitive Strengths & Weaknesses
7.10 Bionic Vision Technologies
7.10.1 Bionic Vision Technologies Details
7.10.2 Bionic Vision Technologies Major Business
7.10.3 Bionic Vision Technologies Inherited Retinal Disease Treatment Product and Services
7.10.4 Bionic Vision Technologies Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Bionic Vision Technologies Recent Developments/Updates
7.10.6 Bionic Vision Technologies Competitive Strengths & Weaknesses
7.11 Coave Therapeutics
7.11.1 Coave Therapeutics Details
7.11.2 Coave Therapeutics Major Business
7.11.3 Coave Therapeutics Inherited Retinal Disease Treatment Product and Services
7.11.4 Coave Therapeutics Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Coave Therapeutics Recent Developments/Updates
7.11.6 Coave Therapeutics Competitive Strengths & Weaknesses
7.12 GenSight Biologics
7.12.1 GenSight Biologics Details
7.12.2 GenSight Biologics Major Business
7.12.3 GenSight Biologics Inherited Retinal Disease Treatment Product and Services
7.12.4 GenSight Biologics Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 GenSight Biologics Recent Developments/Updates
7.12.6 GenSight Biologics Competitive Strengths & Weaknesses
7.13 Ionis Pharmaceuticals
7.13.1 Ionis Pharmaceuticals Details
7.13.2 Ionis Pharmaceuticals Major Business
7.13.3 Ionis Pharmaceuticals Inherited Retinal Disease Treatment Product and Services
7.13.4 Ionis Pharmaceuticals Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Ionis Pharmaceuticals Recent Developments/Updates
7.13.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
7.14 IVERIC BIO
7.14.1 IVERIC BIO Details
7.14.2 IVERIC BIO Major Business
7.14.3 IVERIC BIO Inherited Retinal Disease Treatment Product and Services
7.14.4 IVERIC BIO Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 IVERIC BIO Recent Developments/Updates
7.14.6 IVERIC BIO Competitive Strengths & Weaknesses
7.15 Johnson & Johnson
7.15.1 Johnson & Johnson Details
7.15.2 Johnson & Johnson Major Business
7.15.3 Johnson & Johnson Inherited Retinal Disease Treatment Product and Services
7.15.4 Johnson & Johnson Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Johnson & Johnson Recent Developments/Updates
7.15.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.16 LKC Technologies
7.16.1 LKC Technologies Details
7.16.2 LKC Technologies Major Business
7.16.3 LKC Technologies Inherited Retinal Disease Treatment Product and Services
7.16.4 LKC Technologies Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 LKC Technologies Recent Developments/Updates
7.16.6 LKC Technologies Competitive Strengths & Weaknesses
7.17 Santen Pharmaceutical
7.17.1 Santen Pharmaceutical Details
7.17.2 Santen Pharmaceutical Major Business
7.17.3 Santen Pharmaceutical Inherited Retinal Disease Treatment Product and Services
7.17.4 Santen Pharmaceutical Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Santen Pharmaceutical Recent Developments/Updates
7.17.6 Santen Pharmaceutical Competitive Strengths & Weaknesses
7.18 He Eye Hospital
7.18.1 He Eye Hospital Details
7.18.2 He Eye Hospital Major Business
7.18.3 He Eye Hospital Inherited Retinal Disease Treatment Product and Services
7.18.4 He Eye Hospital Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 He Eye Hospital Recent Developments/Updates
7.18.6 He Eye Hospital Competitive Strengths & Weaknesses
7.19 Bgi Genomics
7.19.1 Bgi Genomics Details
7.19.2 Bgi Genomics Major Business
7.19.3 Bgi Genomics Inherited Retinal Disease Treatment Product and Services
7.19.4 Bgi Genomics Inherited Retinal Disease Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Bgi Genomics Recent Developments/Updates
7.19.6 Bgi Genomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Inherited Retinal Disease Treatment Industry Chain
8.2 Inherited Retinal Disease Treatment Upstream Analysis
8.2.1 Inherited Retinal Disease Treatment Core Raw Materials
8.2.2 Main Manufacturers of Inherited Retinal Disease Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Inherited Retinal Disease Treatment Production Mode
8.6 Inherited Retinal Disease Treatment Procurement Model
8.7 Inherited Retinal Disease Treatment Industry Sales Model and Sales Channels
8.7.1 Inherited Retinal Disease Treatment Sales Model
8.7.2 Inherited Retinal Disease Treatment Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Inherited Retinal Disease Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Inherited Retinal Disease Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Inherited Retinal Disease Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Inherited Retinal Disease Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Inherited Retinal Disease Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Inherited Retinal Disease Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Inherited Retinal Disease Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Inherited Retinal Disease Treatment Production Market Share by Region (2018-2023)
Table 9. World Inherited Retinal Disease Treatment Production Market Share by Region (2024-2029)
Table 10. World Inherited Retinal Disease Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Inherited Retinal Disease Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Inherited Retinal Disease Treatment Major Market Trends
Table 13. World Inherited Retinal Disease Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Inherited Retinal Disease Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Inherited Retinal Disease Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Inherited Retinal Disease Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Inherited Retinal Disease Treatment Producers in 2022
Table 18. World Inherited Retinal Disease Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Inherited Retinal Disease Treatment Producers in 2022
Table 20. World Inherited Retinal Disease Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Inherited Retinal Disease Treatment Company Evaluation Quadrant
Table 22. World Inherited Retinal Disease Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Inherited Retinal Disease Treatment Production Site of Key Manufacturer
Table 24. Inherited Retinal Disease Treatment Market: Company Product Type Footprint
Table 25. Inherited Retinal Disease Treatment Market: Company Product Application Footprint
Table 26. Inherited Retinal Disease Treatment Competitive Factors
Table 27. Inherited Retinal Disease Treatment New Entrant and Capacity Expansion Plans
Table 28. Inherited Retinal Disease Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Inherited Retinal Disease Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Inherited Retinal Disease Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Inherited Retinal Disease Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Inherited Retinal Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Inherited Retinal Disease Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Inherited Retinal Disease Treatment Production Market Share (2018-2023)
Table 37. China Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Inherited Retinal Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Inherited Retinal Disease Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Inherited Retinal Disease Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production Market Share (2018-2023)
Table 47. World Inherited Retinal Disease Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Inherited Retinal Disease Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Inherited Retinal Disease Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Inherited Retinal Disease Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Inherited Retinal Disease Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Inherited Retinal Disease Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Inherited Retinal Disease Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Inherited Retinal Disease Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Inherited Retinal Disease Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Inherited Retinal Disease Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Inherited Retinal Disease Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Inherited Retinal Disease Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Inherited Retinal Disease Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Inherited Retinal Disease Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. Spark Therapeutics Major Business
Table 63. Spark Therapeutics Inherited Retinal Disease Treatment Product and Services
Table 64. Spark Therapeutics Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Spark Therapeutics Recent Developments/Updates
Table 66. Spark Therapeutics Competitive Strengths & Weaknesses
Table 67. Novartis Basic Information, Manufacturing Base and Competitors
Table 68. Novartis Major Business
Table 69. Novartis Inherited Retinal Disease Treatment Product and Services
Table 70. Novartis Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis Recent Developments/Updates
Table 72. Novartis Competitive Strengths & Weaknesses
Table 73. Okuvision Basic Information, Manufacturing Base and Competitors
Table 74. Okuvision Major Business
Table 75. Okuvision Inherited Retinal Disease Treatment Product and Services
Table 76. Okuvision Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Okuvision Recent Developments/Updates
Table 78. Okuvision Competitive Strengths & Weaknesses
Table 79. NIDEK Basic Information, Manufacturing Base and Competitors
Table 80. NIDEK Major Business
Table 81. NIDEK Inherited Retinal Disease Treatment Product and Services
Table 82. NIDEK Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. NIDEK Recent Developments/Updates
Table 84. NIDEK Competitive Strengths & Weaknesses
Table 85. Invitae Basic Information, Manufacturing Base and Competitors
Table 86. Invitae Major Business
Table 87. Invitae Inherited Retinal Disease Treatment Product and Services
Table 88. Invitae Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Invitae Recent Developments/Updates
Table 90. Invitae Competitive Strengths & Weaknesses
Table 91. ZEISS INTERNATIONAL Basic Information, Manufacturing Base and Competitors
Table 92. ZEISS INTERNATIONAL Major Business
Table 93. ZEISS INTERNATIONAL Inherited Retinal Disease Treatment Product and Services
Table 94. ZEISS INTERNATIONAL Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. ZEISS INTERNATIONAL Recent Developments/Updates
Table 96. ZEISS INTERNATIONAL Competitive Strengths & Weaknesses
Table 97. MeiraGTx Basic Information, Manufacturing Base and Competitors
Table 98. MeiraGTx Major Business
Table 99. MeiraGTx Inherited Retinal Disease Treatment Product and Services
Table 100. MeiraGTx Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. MeiraGTx Recent Developments/Updates
Table 102. MeiraGTx Competitive Strengths & Weaknesses
Table 103. Neurosoft Basic Information, Manufacturing Base and Competitors
Table 104. Neurosoft Major Business
Table 105. Neurosoft Inherited Retinal Disease Treatment Product and Services
Table 106. Neurosoft Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Neurosoft Recent Developments/Updates
Table 108. Neurosoft Competitive Strengths & Weaknesses
Table 109. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 110. Astellas Pharma Major Business
Table 111. Astellas Pharma Inherited Retinal Disease Treatment Product and Services
Table 112. Astellas Pharma Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Astellas Pharma Recent Developments/Updates
Table 114. Astellas Pharma Competitive Strengths & Weaknesses
Table 115. Bionic Vision Technologies Basic Information, Manufacturing Base and Competitors
Table 116. Bionic Vision Technologies Major Business
Table 117. Bionic Vision Technologies Inherited Retinal Disease Treatment Product and Services
Table 118. Bionic Vision Technologies Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Bionic Vision Technologies Recent Developments/Updates
Table 120. Bionic Vision Technologies Competitive Strengths & Weaknesses
Table 121. Coave Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Coave Therapeutics Major Business
Table 123. Coave Therapeutics Inherited Retinal Disease Treatment Product and Services
Table 124. Coave Therapeutics Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Coave Therapeutics Recent Developments/Updates
Table 126. Coave Therapeutics Competitive Strengths & Weaknesses
Table 127. GenSight Biologics Basic Information, Manufacturing Base and Competitors
Table 128. GenSight Biologics Major Business
Table 129. GenSight Biologics Inherited Retinal Disease Treatment Product and Services
Table 130. GenSight Biologics Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. GenSight Biologics Recent Developments/Updates
Table 132. GenSight Biologics Competitive Strengths & Weaknesses
Table 133. Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 134. Ionis Pharmaceuticals Major Business
Table 135. Ionis Pharmaceuticals Inherited Retinal Disease Treatment Product and Services
Table 136. Ionis Pharmaceuticals Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Ionis Pharmaceuticals Recent Developments/Updates
Table 138. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 139. IVERIC BIO Basic Information, Manufacturing Base and Competitors
Table 140. IVERIC BIO Major Business
Table 141. IVERIC BIO Inherited Retinal Disease Treatment Product and Services
Table 142. IVERIC BIO Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. IVERIC BIO Recent Developments/Updates
Table 144. IVERIC BIO Competitive Strengths & Weaknesses
Table 145. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 146. Johnson & Johnson Major Business
Table 147. Johnson & Johnson Inherited Retinal Disease Treatment Product and Services
Table 148. Johnson & Johnson Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Johnson & Johnson Recent Developments/Updates
Table 150. Johnson & Johnson Competitive Strengths & Weaknesses
Table 151. LKC Technologies Basic Information, Manufacturing Base and Competitors
Table 152. LKC Technologies Major Business
Table 153. LKC Technologies Inherited Retinal Disease Treatment Product and Services
Table 154. LKC Technologies Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. LKC Technologies Recent Developments/Updates
Table 156. LKC Technologies Competitive Strengths & Weaknesses
Table 157. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 158. Santen Pharmaceutical Major Business
Table 159. Santen Pharmaceutical Inherited Retinal Disease Treatment Product and Services
Table 160. Santen Pharmaceutical Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Santen Pharmaceutical Recent Developments/Updates
Table 162. Santen Pharmaceutical Competitive Strengths & Weaknesses
Table 163. He Eye Hospital Basic Information, Manufacturing Base and Competitors
Table 164. He Eye Hospital Major Business
Table 165. He Eye Hospital Inherited Retinal Disease Treatment Product and Services
Table 166. He Eye Hospital Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. He Eye Hospital Recent Developments/Updates
Table 168. Bgi Genomics Basic Information, Manufacturing Base and Competitors
Table 169. Bgi Genomics Major Business
Table 170. Bgi Genomics Inherited Retinal Disease Treatment Product and Services
Table 171. Bgi Genomics Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 172. Global Key Players of Inherited Retinal Disease Treatment Upstream (Raw Materials)
Table 173. Inherited Retinal Disease Treatment Typical Customers
Table 174. Inherited Retinal Disease Treatment Typical Distributors
LIST OF FIGURE
Figure 1. Inherited Retinal Disease Treatment Picture
Figure 2. World Inherited Retinal Disease Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Inherited Retinal Disease Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Inherited Retinal Disease Treatment Production (2018-2029) & (K Units)
Figure 5. World Inherited Retinal Disease Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Inherited Retinal Disease Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Inherited Retinal Disease Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Inherited Retinal Disease Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Inherited Retinal Disease Treatment Production (2018-2029) & (K Units)
Figure 10. China Inherited Retinal Disease Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Inherited Retinal Disease Treatment Production (2018-2029) & (K Units)
Figure 12. Inherited Retinal Disease Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Inherited Retinal Disease Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Inherited Retinal Disease Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Inherited Retinal Disease Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Inherited Retinal Disease Treatment Markets in 2022
Figure 26. United States VS China: Inherited Retinal Disease Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Inherited Retinal Disease Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Inherited Retinal Disease Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Inherited Retinal Disease Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Inherited Retinal Disease Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production Market Share 2022
Figure 32. World Inherited Retinal Disease Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Inherited Retinal Disease Treatment Production Value Market Share by Type in 2022
Figure 34. Gene Therapy
Figure 35. Artificial Retina
Figure 36. Neuroprotectant
Figure 37. World Inherited Retinal Disease Treatment Production Market Share by Type (2018-2029)
Figure 38. World Inherited Retinal Disease Treatment Production Value Market Share by Type (2018-2029)
Figure 39. World Inherited Retinal Disease Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Inherited Retinal Disease Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Inherited Retinal Disease Treatment Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. World Inherited Retinal Disease Treatment Production Market Share by Application (2018-2029)
Figure 45. World Inherited Retinal Disease Treatment Production Value Market Share by Application (2018-2029)
Figure 46. World Inherited Retinal Disease Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Inherited Retinal Disease Treatment Industry Chain
Figure 48. Inherited Retinal Disease Treatment Procurement Model
Figure 49. Inherited Retinal Disease Treatment Sales Model
Figure 50. Inherited Retinal Disease Treatment Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Inherited Retinal Disease Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Inherited Retinal Disease Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Inherited Retinal Disease Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Inherited Retinal Disease Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Inherited Retinal Disease Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Inherited Retinal Disease Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Inherited Retinal Disease Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Inherited Retinal Disease Treatment Production Market Share by Region (2018-2023)
Table 9. World Inherited Retinal Disease Treatment Production Market Share by Region (2024-2029)
Table 10. World Inherited Retinal Disease Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Inherited Retinal Disease Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Inherited Retinal Disease Treatment Major Market Trends
Table 13. World Inherited Retinal Disease Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Inherited Retinal Disease Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Inherited Retinal Disease Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Inherited Retinal Disease Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Inherited Retinal Disease Treatment Producers in 2022
Table 18. World Inherited Retinal Disease Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Inherited Retinal Disease Treatment Producers in 2022
Table 20. World Inherited Retinal Disease Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Inherited Retinal Disease Treatment Company Evaluation Quadrant
Table 22. World Inherited Retinal Disease Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Inherited Retinal Disease Treatment Production Site of Key Manufacturer
Table 24. Inherited Retinal Disease Treatment Market: Company Product Type Footprint
Table 25. Inherited Retinal Disease Treatment Market: Company Product Application Footprint
Table 26. Inherited Retinal Disease Treatment Competitive Factors
Table 27. Inherited Retinal Disease Treatment New Entrant and Capacity Expansion Plans
Table 28. Inherited Retinal Disease Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Inherited Retinal Disease Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Inherited Retinal Disease Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Inherited Retinal Disease Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Inherited Retinal Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Inherited Retinal Disease Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Inherited Retinal Disease Treatment Production Market Share (2018-2023)
Table 37. China Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Inherited Retinal Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Inherited Retinal Disease Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Inherited Retinal Disease Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Inherited Retinal Disease Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production Market Share (2018-2023)
Table 47. World Inherited Retinal Disease Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Inherited Retinal Disease Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Inherited Retinal Disease Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Inherited Retinal Disease Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Inherited Retinal Disease Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Inherited Retinal Disease Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Inherited Retinal Disease Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Inherited Retinal Disease Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Inherited Retinal Disease Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Inherited Retinal Disease Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Inherited Retinal Disease Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Inherited Retinal Disease Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Inherited Retinal Disease Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Inherited Retinal Disease Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. Spark Therapeutics Major Business
Table 63. Spark Therapeutics Inherited Retinal Disease Treatment Product and Services
Table 64. Spark Therapeutics Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Spark Therapeutics Recent Developments/Updates
Table 66. Spark Therapeutics Competitive Strengths & Weaknesses
Table 67. Novartis Basic Information, Manufacturing Base and Competitors
Table 68. Novartis Major Business
Table 69. Novartis Inherited Retinal Disease Treatment Product and Services
Table 70. Novartis Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis Recent Developments/Updates
Table 72. Novartis Competitive Strengths & Weaknesses
Table 73. Okuvision Basic Information, Manufacturing Base and Competitors
Table 74. Okuvision Major Business
Table 75. Okuvision Inherited Retinal Disease Treatment Product and Services
Table 76. Okuvision Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Okuvision Recent Developments/Updates
Table 78. Okuvision Competitive Strengths & Weaknesses
Table 79. NIDEK Basic Information, Manufacturing Base and Competitors
Table 80. NIDEK Major Business
Table 81. NIDEK Inherited Retinal Disease Treatment Product and Services
Table 82. NIDEK Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. NIDEK Recent Developments/Updates
Table 84. NIDEK Competitive Strengths & Weaknesses
Table 85. Invitae Basic Information, Manufacturing Base and Competitors
Table 86. Invitae Major Business
Table 87. Invitae Inherited Retinal Disease Treatment Product and Services
Table 88. Invitae Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Invitae Recent Developments/Updates
Table 90. Invitae Competitive Strengths & Weaknesses
Table 91. ZEISS INTERNATIONAL Basic Information, Manufacturing Base and Competitors
Table 92. ZEISS INTERNATIONAL Major Business
Table 93. ZEISS INTERNATIONAL Inherited Retinal Disease Treatment Product and Services
Table 94. ZEISS INTERNATIONAL Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. ZEISS INTERNATIONAL Recent Developments/Updates
Table 96. ZEISS INTERNATIONAL Competitive Strengths & Weaknesses
Table 97. MeiraGTx Basic Information, Manufacturing Base and Competitors
Table 98. MeiraGTx Major Business
Table 99. MeiraGTx Inherited Retinal Disease Treatment Product and Services
Table 100. MeiraGTx Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. MeiraGTx Recent Developments/Updates
Table 102. MeiraGTx Competitive Strengths & Weaknesses
Table 103. Neurosoft Basic Information, Manufacturing Base and Competitors
Table 104. Neurosoft Major Business
Table 105. Neurosoft Inherited Retinal Disease Treatment Product and Services
Table 106. Neurosoft Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Neurosoft Recent Developments/Updates
Table 108. Neurosoft Competitive Strengths & Weaknesses
Table 109. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 110. Astellas Pharma Major Business
Table 111. Astellas Pharma Inherited Retinal Disease Treatment Product and Services
Table 112. Astellas Pharma Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Astellas Pharma Recent Developments/Updates
Table 114. Astellas Pharma Competitive Strengths & Weaknesses
Table 115. Bionic Vision Technologies Basic Information, Manufacturing Base and Competitors
Table 116. Bionic Vision Technologies Major Business
Table 117. Bionic Vision Technologies Inherited Retinal Disease Treatment Product and Services
Table 118. Bionic Vision Technologies Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Bionic Vision Technologies Recent Developments/Updates
Table 120. Bionic Vision Technologies Competitive Strengths & Weaknesses
Table 121. Coave Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Coave Therapeutics Major Business
Table 123. Coave Therapeutics Inherited Retinal Disease Treatment Product and Services
Table 124. Coave Therapeutics Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Coave Therapeutics Recent Developments/Updates
Table 126. Coave Therapeutics Competitive Strengths & Weaknesses
Table 127. GenSight Biologics Basic Information, Manufacturing Base and Competitors
Table 128. GenSight Biologics Major Business
Table 129. GenSight Biologics Inherited Retinal Disease Treatment Product and Services
Table 130. GenSight Biologics Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. GenSight Biologics Recent Developments/Updates
Table 132. GenSight Biologics Competitive Strengths & Weaknesses
Table 133. Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 134. Ionis Pharmaceuticals Major Business
Table 135. Ionis Pharmaceuticals Inherited Retinal Disease Treatment Product and Services
Table 136. Ionis Pharmaceuticals Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Ionis Pharmaceuticals Recent Developments/Updates
Table 138. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 139. IVERIC BIO Basic Information, Manufacturing Base and Competitors
Table 140. IVERIC BIO Major Business
Table 141. IVERIC BIO Inherited Retinal Disease Treatment Product and Services
Table 142. IVERIC BIO Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. IVERIC BIO Recent Developments/Updates
Table 144. IVERIC BIO Competitive Strengths & Weaknesses
Table 145. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 146. Johnson & Johnson Major Business
Table 147. Johnson & Johnson Inherited Retinal Disease Treatment Product and Services
Table 148. Johnson & Johnson Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Johnson & Johnson Recent Developments/Updates
Table 150. Johnson & Johnson Competitive Strengths & Weaknesses
Table 151. LKC Technologies Basic Information, Manufacturing Base and Competitors
Table 152. LKC Technologies Major Business
Table 153. LKC Technologies Inherited Retinal Disease Treatment Product and Services
Table 154. LKC Technologies Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. LKC Technologies Recent Developments/Updates
Table 156. LKC Technologies Competitive Strengths & Weaknesses
Table 157. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 158. Santen Pharmaceutical Major Business
Table 159. Santen Pharmaceutical Inherited Retinal Disease Treatment Product and Services
Table 160. Santen Pharmaceutical Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Santen Pharmaceutical Recent Developments/Updates
Table 162. Santen Pharmaceutical Competitive Strengths & Weaknesses
Table 163. He Eye Hospital Basic Information, Manufacturing Base and Competitors
Table 164. He Eye Hospital Major Business
Table 165. He Eye Hospital Inherited Retinal Disease Treatment Product and Services
Table 166. He Eye Hospital Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. He Eye Hospital Recent Developments/Updates
Table 168. Bgi Genomics Basic Information, Manufacturing Base and Competitors
Table 169. Bgi Genomics Major Business
Table 170. Bgi Genomics Inherited Retinal Disease Treatment Product and Services
Table 171. Bgi Genomics Inherited Retinal Disease Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 172. Global Key Players of Inherited Retinal Disease Treatment Upstream (Raw Materials)
Table 173. Inherited Retinal Disease Treatment Typical Customers
Table 174. Inherited Retinal Disease Treatment Typical Distributors
LIST OF FIGURE
Figure 1. Inherited Retinal Disease Treatment Picture
Figure 2. World Inherited Retinal Disease Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Inherited Retinal Disease Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Inherited Retinal Disease Treatment Production (2018-2029) & (K Units)
Figure 5. World Inherited Retinal Disease Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Inherited Retinal Disease Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Inherited Retinal Disease Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Inherited Retinal Disease Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Inherited Retinal Disease Treatment Production (2018-2029) & (K Units)
Figure 10. China Inherited Retinal Disease Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Inherited Retinal Disease Treatment Production (2018-2029) & (K Units)
Figure 12. Inherited Retinal Disease Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Inherited Retinal Disease Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Inherited Retinal Disease Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Inherited Retinal Disease Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Inherited Retinal Disease Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Inherited Retinal Disease Treatment Markets in 2022
Figure 26. United States VS China: Inherited Retinal Disease Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Inherited Retinal Disease Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Inherited Retinal Disease Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Inherited Retinal Disease Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Inherited Retinal Disease Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Inherited Retinal Disease Treatment Production Market Share 2022
Figure 32. World Inherited Retinal Disease Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Inherited Retinal Disease Treatment Production Value Market Share by Type in 2022
Figure 34. Gene Therapy
Figure 35. Artificial Retina
Figure 36. Neuroprotectant
Figure 37. World Inherited Retinal Disease Treatment Production Market Share by Type (2018-2029)
Figure 38. World Inherited Retinal Disease Treatment Production Value Market Share by Type (2018-2029)
Figure 39. World Inherited Retinal Disease Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Inherited Retinal Disease Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Inherited Retinal Disease Treatment Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Clinic
Figure 44. World Inherited Retinal Disease Treatment Production Market Share by Application (2018-2029)
Figure 45. World Inherited Retinal Disease Treatment Production Value Market Share by Application (2018-2029)
Figure 46. World Inherited Retinal Disease Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Inherited Retinal Disease Treatment Industry Chain
Figure 48. Inherited Retinal Disease Treatment Procurement Model
Figure 49. Inherited Retinal Disease Treatment Sales Model
Figure 50. Inherited Retinal Disease Treatment Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
